Versartis Appoints Joshua Brumm As CFO - Quick Facts

(RTTNews) - Versartis Inc. announced that it has appointed Joshua Brumm as its first Chief Financial Officer. Brumm will report to Chief Executive Officer Jeffrey Cleland, and will lead the company's financial operations including responsibility for investor relations.

Most recently, Brumm was Executive Vice President of Finance at Pharmacyclics Inc. (PCYC), where he was the Principal Financial Officer and Principal Accounting Officer with responsibilities for Corporate Finance, IT, Facilities and Procurement. Previously, as Chief Financial Officer and Senior Vice President for ZELTIQ Aesthetics Inc. (ZLTQ), he led the company's 2011 initial public offering and also served in senior leadership roles in International Sales, Corporate Development and Investor Relations.

Before joining to ZELTIQ, Brumm served as Director of Finance at Proteolix Inc., a private biotechnology company acquired by Onyx Pharmaceuticals.

Earlier in his career, Brumm held the positions of Investment Banking Associate as a member of the West Coast Healthcare Team at Citigroup Global Markets, Inc. and as an Investment Banking Analyst for the West Coast Healthcare Team at Morgan Stanley.